Colorectal Neoplasms: all 5,734 studies
Page 52 of 58. Open to participants first (1,481), then studies with results posted, then the rest; newest registration first within each.
- IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)CompletedNCT00785122Phase 1/2
- Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and ErlotinibStatus unknownNCT00784667Phase 2
- First-line Therapy of Stage IV Colorectal CancerCompletedNCT00784446Phase 1/2
- Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal CancerWithdrawnNCT00780988Phase 1
- Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal CancerCompletedNCT00780169Phase 1
- Capiri-sutent Phase-1 in Advanced Colo-rectal CancerStatus unknownNCT00777478Phase 1
- Longitudinal Study of Symptoms in Colorectal CancerTerminatedNCT00777192
- Radiofrequency Ablation in Resectable Colorectal Lung MetastasisCompletedNCT00776399Phase 2
- Caring for Those Who Share: Improving the Health of Wisconsin Blood DonorsCompletedNCT00772083Not applicable
- Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal CancerCompletedNCT00769405Phase 3
- Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to LiverWithdrawnNCT00766220Phase 2
- Randomised Controlled Trial of a Literacy Sensitive Decision Aid for Bowel Cancer ScreeningStatus unknownNCT00765869Not applicable
- Comparison of Transparent Retractable Extension Device and Narrow Band Imaging on Colorectal Adenoma DetectionCompletedNCT00765180Not applicable
- Health Economic Evaluation of Primovist-enhanced Liver MRICompletedNCT00764621Phase 4
- Prospective Randomized Comparison of Cold Snare Polypectomy and Conventional PolypectomyCompletedNCT00763425Not applicable
- Randomized Trial of Colonic Stents as a Bridge to SurgeryCompletedNCT00758186Phase 3
- Study of Genes and the Environment in Patients With Colorectal Cancer in the East Anglia Region of the United KingdomStatus unknownNCT00757965
- Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRCTerminatedNCT00755534Phase 2
- Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic CrcTerminatedNCT00755118Phase 2
- A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal CarcinomaCompletedNCT00752570Phase 2
- Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal CancerCompletedNCT00749450Phase 3
- Colonography Versus Colonoscopy in High Risk PatientTerminatedNCT00748449Not applicable
- Application of CO2 Insufflations in Colonoscopy Randomized TrialStatus unknownNCT00745927Not applicable
- Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver MetastasisCompletedNCT00743678Phase 2
- Increasing Colorectal Cancer Screening Among Filipino AmericansCompletedNCT00742729Not applicable
- PET Evaluation of Response After 1 Course of Chemotherapy as Predictor of Treatment Outcome.CompletedNCT00741481
- A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)CompletedNCT00739453Phase 1
- Cardiopulmonary Exercise Testing and Preoperative Risk StratificationCompletedNCT00737828Not applicable
- Evaluation of an Intervention to Increase Colorectal Cancer Screening in Primary Care ClinicsCompletedNCT00737646Not applicable
- FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal CarcinomaWithdrawnNCT00735241Phase 2/3
- Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal CarcinomaWithdrawnNCT00725400Phase 2
- Randomized Phase II Study of SOL for Untreated Metastatic Colorectal CancerCompletedNCT00721916Phase 2
- Colorectal Cancer Screening Validation StudyStatus unknownNCT00720993
- Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and BevacizumabTerminatedNCT00720512Phase 3
- Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00719797Phase 3
- Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal CancerTerminatedNCT00719199Phase 1
- Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer PatientsWithdrawnNCT00718055
- Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage TreatmentTerminatedNCT00717990Phase 2
- Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-based TherapyCompletedNCT00713128
- Study of the Therapeutic Use of Language in Patients With Metastatic Colorectal CancerCompletedNCT00711672
- A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01)CompletedNCT00709462Phase 1
- Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal CancerCompletedNCT00707889Phase 2
- Adherence and the Economics of Colon Cancer ScreeningCompletedNCT00705731
- Nelfinavir, a Phase I/Phase II Rectal Cancer StudyCompletedNCT00704600Phase 1/2
- Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation AssayCompletedNCT00696345
- Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal CancerCompletedNCT00695201Phase 1
- Improving Outcomes for Patients Requiring Oral Bowel Preparation for ColonoscopyStatus unknownNCT00693290Not applicable
- Phase II Trial of LBH589 in Refractory Colorectal CancerCompletedNCT00690677Phase 2
- Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal CancerCompletedNCT00689624Phase 2
- Comprehensive Therapy to Relieving the Risk of Recurrence and Metastasis for Colorectal CancerStatus unknownNCT00689364
- Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous PolyposisCompletedNCT00685568Phase 1
- Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their CaregiversCompletedNCT00684801
- Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal CancerTerminatedNCT00681876Phase 2
- Impact of Microparticles on Postoperative Complications in Surgical PatientsCompletedNCT00677781
- Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal CancerTerminatedNCT00677612Phase 1/2
- Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal CancerCompletedNCT00677443Phase 3
- Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal CancerTerminatedNCT00677287Phase 1/2
- Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal CancerCompletedNCT00677144Phase 2
- Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal CancerCompletedNCT00675636
- Trial of Second Generation Designer T Cells in Colorectal CarcinomaTerminatedNCT00673322Phase 1
- Interactive Computer Program or Brochure in Increasing Colorectal Cancer Screening Among African AmericansCompletedNCT00672828Not applicable
- A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal CancerCompletedNCT00671372Phase 1
- Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility ProjectCompletedNCT00661154
- FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS TumorCompletedNCT00660582Phase 2
- Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal CancersCompletedNCT00660153Phase 1
- Neo-adjuvant Therapy and the Effect on Synchronous Metastatic GrowthStatus unknownNCT00659022Phase 2
- Focusing Implementation to Bring Effective Reminders (FIBER)CompletedNCT00656838Not applicable
- Study of Colon GVAX and Cyclophosphamide in Patients With Metastatic Colorectal CancerCompletedNCT00656123Phase 1
- Energy Balance Interventions for Colorectal Cancer PreventionCompletedNCT00653484Not applicable
- Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian CancerCompletedNCT00648102Phase 1
- Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal CancerCompletedNCT00647153Phase 1
- Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal CancerStatus unknownNCT00643877Phase 3
- A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer.CompletedNCT00642577Phase 3
- Peptide Vaccine and S-1/CPT-11 Therapy for Patients With Unresectable Advanced Colorectal CancerCompletedNCT00641615Phase 1
- Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal CancerCompletedNCT00640471Phase 3
- Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal CancerCompletedNCT00640081Phase 2
- Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) ExpressionsCompletedNCT00637091Phase 2
- Screening for Familial Colorectal Cancer (CRC) PatientsCompletedNCT00632515
- Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver MetastasisStatus unknownNCT00630045Phase 3
- Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal CancerCompletedNCT00628810Phase 2
- Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal CancerCompletedNCT00628368Not applicable
- Comparison of Two Methods of Administration of a PEG SolutionCompletedNCT00626054Phase 4
- Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal CancerCompletedNCT00625651Phase 1/2
- Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal CancerStatus unknownNCT00625625Phase 2
- Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing ColonoscopyCompletedNCT00625066
- Impact of PET Scan on the Curative Strategy of Colo-rectal Cancers : A Randomized StudyCompletedNCT00624260Not applicable
- Colonoscopic Removal of Aberrant Crypt Foci: a Prospective, Randomized, Blinded TrialCompletedNCT00623883Not applicable
- Is Barium Enema an Adequate Diagnostic Test for Patients With Positive FOBT?CompletedNCT00619814Not applicable
- Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy ParticipantsStatus unknownNCT00617071Phase 3
- Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal NeoplasiaCompletedNCT00611000Phase 1
- Treatment Outcomes of Hepatic Metastasis After FOLFOX-4 TherapyStatus unknownNCT00610636Phase 3
- Dietary Bioflavonoid Supplementation for the Prevention of Neoplasia RecurrenceSuspendedNCT00609310Phase 2
- Combined Resection of Colorectal MetastasesCompletedNCT00606398Phase 2
- Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based RegimensTerminatedNCT00603577Phase 3
- MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal CancerTerminatedNCT00602329Phase 2
- A Pilot Study of PPX in Women With Metastatic Colorectal CancerCompletedNCT00598247Phase 1
- Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- TarcevaCompletedNCT00598156Phase 3
- Phase I/II Combination With Irinotecan- ErbituxCompletedNCT00594984Phase 1/2
- Feasibility Study of Neoadjuvant Chemotherapy Modified FOLFOX6 for Resectable Liver Metastases of Colorectal CancersStatus unknownNCT00594529Phase 2
- "Touch 2 Screen" Multi-media Colorectal Cancer Screening InterventionCompletedNCT00594113Not applicable